Tarsus Pharmaceuticals, Inc. — SC 13G/A Filings
28 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Tarsus Pharmaceuticals, Inc. (TARS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Tarsus Pharmaceuticals, Inc. has filed 28 SC 13G/A documents with the SEC since 2020. To view all SEC filings by Tarsus Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0001172661-24-005050 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119045 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000932471-24-001309 | Nov 12, 2024 | — |
| SC 13G/A | — | 0002012383-24-003994 | Nov 8, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-251788 | Nov 6, 2024 | — |
| SC 13G/A | — | 0000932471-24-000741 | Nov 4, 2024 | — |
| SC 13G/A | — | 0002012383-24-000970 | Oct 21, 2024 | — |
| SC 13G/A | TARSUS PHARMACEUTICALS, INC. | 0000902664-24-001556 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 4 | 0000929638-24-000648 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002880 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-24-013410 | Feb 13, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-022201 | Feb 2, 2024 | — |
| SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 0001085146-24-000653 | Feb 2, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-038735 | Feb 14, 2023 | — |
| SC 13G/A | TARSUS PHARMACEUTICALS, INC. | 0000902664-23-001726 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-23-010904 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-23-002407 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000929638-23-000555 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001193805-23-000159 | Feb 10, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-041979 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000929638-22-000471 | Feb 14, 2022 | — |
| SC 13G/A | TARSUS PHARMACEUTICALS, INC. | 0000902664-22-001587 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-041990 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042273 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-22-007082 | Feb 11, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-021382 | Jan 28, 2022 | — |
| SC 13G/A | — | 0000929638-21-000380 | Feb 16, 2021 | — |
| SC 13G/A | — | 0001493152-21-003517 | Feb 12, 2021 | — |